Collectively, these data show that E2F and ETS-mediated transcription is altered in CDKi-resistant ovarian cancer cells, reflecting the differential activation of different drivers of E2F-mediated transcription, including cyclin E1 and RTK/RAS signaling. The gene discussed is CCNE1; the disease is ovarian cancer.